Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, Massachusetts
- Most recent report
- 10-Q, filed Aug 10, 2026
- Incorporated
- Delaware
- Filings on record
- 506 filings
- On EDGAR
- CIK 1798749
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 21
News 8 of 59
Prospectuses and Registrations 8 of 34
- 424B5 Prospectus supplement for an offering Jun 4, 2026
- 424B5 Prospectus supplement for an offering Jun 3, 2026
- 424B3 Prospectus supplement for an offering May 15, 2026
- S-8 Registration statement for an employee plan May 7, 2026
- S-3 Shelf registration statement May 7, 2026
- S-3 Shelf registration statement May 7, 2026
- 424B3 Prospectus supplement for an offering May 7, 2026
- 424B3 Prospectus supplement for an offering May 7, 2026
Proxies 8 of 10
- DEFA14A Extra proxy material Jun 5, 2026
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- PRE 14A Preliminary proxy statement Apr 17, 2026
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 19, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 19, 2023
Ownership 8 of 319
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 8, 2026
- 4 Insider reported a trade Jun 26, 2026
- 3 Insider reported their initial holding Jun 26, 2026
- 4 Insider reported a trade Jun 11, 2026
- 4 Insider reported a trade Jun 11, 2026
Other 8 of 63
- EFFECT Notice that a registration became effective May 15, 2026
- EFFECT Notice that a registration became effective May 15, 2026
- CORRESP Reply to SEC staff May 13, 2026
- CORRESP Reply to SEC staff May 13, 2026
- UPLOAD Comment letter from SEC staff May 13, 2026
- UPLOAD Comment letter from SEC staff May 13, 2026
- ARS Annual report sent to shareholders Apr 28, 2026
- POS EX Mar 6, 2026
Everything here comes from Jade Biosciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.